|
|
Advertisement |
 |
|
|
Advertisement |
The world is larger than you think - Don't get lost
Cultural insight the key to doing business in a globalized world. Become a global business insider with Pharma Reports, a series of PDF-format reports detailing the latest market conditions and opportunities in more than 10 countries.
Explore now
|
|
Advertisement |
Don't let your campaign fall apart
Strategic product management is the glue holding an operation together. This Pharmaceutical Executive handbook is your go-to guide for effective and profitable product management.
Read more
|
|
Organizational Effectiveness |
|
Advertisement |
A Framework for Successful Biopharma Launches Understanding the launch archetype and identifying critical success factors
On Demand
Learn more
|
|
|
|
/ August 14–15: Publication Planning 2018 / |
Philadelphia, PA |
/ August 15–16: Reimbursement and Access 2018 / |
Philadelphia, PA |
/ August 20–22: Transparency and Aggregate Spend 2018 / |
Washington, DA, PA |
/ September 25–26: Finance and Accounting for Bioscience Companies / |
Boston, MA |
/ September 25–26: 4th Annual Bio/Pharmaceutical Product Launch Summit / |
Cambridge, MA |
/ September 27: 3rd Edition Drug Pricing Transparency Congress / |
Philadelphia, PA |
/ October 2–3: Advanced Therapies Commercialization Congress / |
Amsterdam, The Netherlands |
/ November 13–14: Due Diligence for Life Sciences M&A, Partnerships and Divestitures / |
Philadelphia, PA |
/ November 14–15: Commercial Data Insights 2018 / |
Philadelphia, PA |
/ November 14–15: 5th Annual Global Compliance Congress for Life Sciences / |
London, UK |
/ November 28–29: Compliant Patient Support Programs Summit / |
Chicago, IL |
/ December 4–5: Managed Markets Compliance Congress
2018
/ |
Philadelphia, PA |
/ December 5–6: Bio/Pharma Compliance Congress on Non-Promotional Activities / |
Philadelphia, PA |
|
|
|
Business Models |
 |
Design Thinking in Pharma |
When design thinking is incorporated into the business model, pharmaceutical businesses can truly differentiate themselves and recognize a valuable impact, writes Adam Taicher
… /Read More/ |
|
|
Advertisement |
Evolving Life Sciences Quality Management: Keeping Up with the New Reality
On Demand
Learn more
|
|
|
Industry update |
//
Robert Bertoldi resigned from the Board of Motif Bio (New York, NY).
//
Rafael Pharmaceuticals (Newark, NJ) appointed Eric Van Cutsem MD, Ph.D., and Josep Tabernero, MD, Ph.D., to its Medical Advisory Board.
//
Orchard Therapeutics (Boston, MA, and London, UK) appointed Joanne Beck, Ph.D., to its Board of Directors.
//
Codexis (Redwood City, CA) appointed Hicham Alaoui, Ph.D., to the newly created position of Vice President, Biotherapeutics Research & Development.
//
Altimmune (Gaithersburg, MD) appointed Mitchel Sayare, Ph.D., as Executive Chairman of the Board.
//
Catalyst Biosciences (South San Francisco, CA) appointed Grant Blouse, Ph.D., as Vice President of Translational Research.
//
Clementia Pharmaceuticals (Montreal, Canada) announced the appointment of Steve Forte as Chief Financial Officer, effective August 3. Shawn Cline Tomasello also joined the company's Board of Directors.
//
Damien King joined the Board of Directors of Aequus Pharmaceuticals (Vancouver, Canada) to fill the seat previously held by Dr. Fotios Plakogiannis, who did not stand for re-election.
//
|
|
|